Status:
WITHDRAWN
Safety Study of Sildenafil in Treatment of Cerebral Aneurysm Vasospasm
Lead Sponsor:
University of Nebraska
Conditions:
Cerebral Vasospasm
Subarachnoid Hemorrhage
Eligibility:
All Genders
19+ years
Phase:
PHASE2
Brief Summary
Rupture of a cerebral aneurysm is a serious medical condition that may result in permanent disability or even death just related to the aneurysm rupture itself. Patients who undergo successful surgica...
Detailed Description
When a cerebral aneurysm ruptures, the surface of the brain and its blood vessels are covered with clotted blood. This condition is called subarachnoid hemorrhage (SAH). Subarachnoid hemorrhage second...
Eligibility Criteria
Inclusion
- Subarachnoid Hemorrhage (Fisher Grade 3)
- Cerebral Aneurysm documented by computed tomography angiography (CTA)/magnetic resonance angiography (MRA)/Cerebral Angiogram
- Enrollment within 48 hours of symptom onset
Exclusion
- Hypersensitivity to Sildenafil
- Pregnancy
- Age less than 19 years
- Concurrent use of nitrates or alpha-blockers
- Aneurysm related to an arteriovenous malformation
- Delayed enrollment past 48 hours
- Subarachnoid hemorrhage that is not Fisher Grade 3
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 25 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00871065
Start Date
July 1 2008
End Date
February 25 2009
Last Update
August 15 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.